These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients.
    Author: Simmons SA, Perry PJ, Rickert ED, Browne JL.
    Journal: J Affect Disord; 1985; 8(1):47-53. PubMed ID: 3156911.
    Abstract:
    A retrospective chart review was conducted on depressed inpatients to determine the economic impact of prospective pharmacokinetic dosing vs. empirical dosing of tricyclic antidepressants. The benefit/cost ratio of 2.5 indicated that the benefits of prospective dosing more than doubled the cost. The prospectively dose patients were discharged significantly earlier, i.e. 6.1 days than the empirically dosed patients and they also returned to work significantly earlier, i.e. 55.4 days than the control group.
    [Abstract] [Full Text] [Related] [New Search]